What's in TherapeuticsMD's pipeline?

TherapeuticsMD has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with TherapeuticsMD's portfolio?

Top competitors by shared drug class: FHI 360, Italfarmaco, Kayseri Education and Research Hospital, Penn State University, University of Alabama at Birmingham.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/therapeuticsmd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

TherapeuticsMD — Portfolio Competitive Intelligence Brief

TherapeuticsMD (TXMD) pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

TXMD (NASDAQ) 1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Segesterone Acetate and Ethinyl Estradiol	Segesterone Acetate and Ethinyl Estradiol	marketed	Hormonal contraceptive	Progesterone receptor (segesterone acetate); estrogen receptor (ethinyl estradiol)	Contraception / Women's Health

Therapeutic area mix

Contraception / Women's Health · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

FHI 360 · 1 shared drug class
Italfarmaco · 1 shared drug class
Kayseri Education and Research Hospital · 1 shared drug class
Penn State University · 1 shared drug class
University of Alabama at Birmingham · 1 shared drug class
University of Athens · 1 shared drug class
University of Pittsburgh · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for TherapeuticsMD:

Cite this brief

Drug Landscape (2026). TherapeuticsMD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/therapeuticsmd. Accessed 2026-05-15.